Charles River Laboratories International, Inc.
CRL
$2.45 (-1.33%)
1D
1W
3M
1Y
5Y
ALL
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Forbes • 11 hours ago • CRL
The Healthcare M&A Wave
24/7 Wall Street • 1 day ago • CRL
Here Are Wednesday's Best Wall Street Analyst Research Calls: Block, Charles River Laboratories, Cognizant Technology, Constellation Energy, Credicorp, First Solar, GE Vernova, Huntsman, Macerich, and More
Zacks Investment Research • 2 days ago • CRL
LH vs. CRL: Which Stock Is the Better Value Option?
Seeking Alpha • 14 days ago • CRL
Charles River Laboratories International, Inc. (CRL) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Business Wire • 15 days ago • CRL
Charles River Associates (CRA) to Present at the Sidoti Small-Cap Virtual Conference
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.